This CD38 CHO recombinant cell line is designed for research applications focusing on CD38-mediated cellular processes and immunotherapy, constitutively expressing full-length human CD38 protein for studying CD38 biology, screening inhibitors, and developing therapies. This high expression level mimics cancer target cells, providing a relevant model for drug discovery and functional assays.
- Physiologically relevant model for studying glycoprotein and ectoenzyme roles
- High-expression model for immunotherapy target antigen investigations
- Confirmed absence of mycoplasma contamination
- Supplied as two vials with approx. 2 x 10^6 cells per vial
- Storage buffer contains 10% DMSO in FBS